{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:46:58Z","timestamp":1747205218426,"version":"3.40.5"},"posted":{"date-parts":[[2024,7,16]]},"group-title":"In Review","reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,7,1]]},"abstract":"<title>Abstract<\/title>\n        <p>The persistence of chronic pain and continuing overdose deaths from pain-relieving opioids targeting \u00b5 opioid receptor (\u00b5OR) have fueled the need for reliable long-term analgesics which use different targets and mechanisms. The \u03b4 opioid receptor (\u03b4OR) is a potential alternative target for non-addictive analgesics to alleviate chronic pain, made more attractive by its lack of respiratory depression associated with \u00b5OR agonists. However, early \u03b4OR full agonists were found to induce seizures, precluding clinical use. Partial \u03b4OR agonists may offer more controlled activation of the receptor compared to full agonists, but the development of such ligands has been hindered by uncertainty over the molecular mechanism mediating partial agonism. Using a structure-based approach, we explored the engagement of the sodium binding pocket in \u03b4OR and developed a bitopic ligand, C6-Quino, predicted to be a selective \u03b4OR partial agonist. Functional studies of C6-Quino revealed that it displayed \u03b4OR partial agonist activity at both G-protein and arrestin pathways. Its interaction with the sodium pocket was confirmed and analyzed using a single particle cryo-EM. Additionally, C6-Quino demonstrated favorable chemical and physiological properties like oral activity, and analgesic activity in multiple chronic pain models. Notably, \u00b5OR-related hyperlocomotion and respiratory depression, and \u03b4OR-related convulsions, were not observed at analgesic doses of C6-Quino. This fundamentally new approach to designing \u03b4OR ligands provides a blueprint for the development of partial agonists as safe analgesics and acts as a generic method to optimize signaling profiles of other Class A GPCRs.<\/p>","DOI":"10.21203\/rs.3.rs-4664764\/v1","type":"posted-content","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:20:45Z","timestamp":1721128845000},"source":"Crossref","is-referenced-by-count":0,"title":["Structure-Guided Design of Partial Agonists at an Opioid Receptor"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-3027","authenticated-orcid":false,"given":"Tao","family":"Che","sequence":"first","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balazs","family":"Varga","sequence":"additional","affiliation":[{"name":"WUSTL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8549-0413","authenticated-orcid":false,"given":"Sarah M","family":"Bernhard","sequence":"additional","affiliation":[{"name":"Washington University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal El","family":"Daibani","sequence":"additional","affiliation":[{"name":"Washington University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saheem","family":"Zaidi","sequence":"additional","affiliation":[{"name":"University of Southern California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-6228","authenticated-orcid":false,"given":"Jordy","family":"Lam","sequence":"additional","affiliation":[{"name":"University of Southern California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-3440","authenticated-orcid":false,"given":"Jhoan","family":"Aguilar","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-3347","authenticated-orcid":false,"given":"Kevin","family":"Appourchaux","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonina","family":"Nazarova","sequence":"additional","affiliation":[{"name":"University of Southern California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Kouvelis","sequence":"additional","affiliation":[{"name":"Washington University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shainnel","family":"Eans","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8777-302X","authenticated-orcid":false,"given":"Elyssa","family":"Margolis","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-2384","authenticated-orcid":false,"given":"Jonathan","family":"Fay","sequence":"additional","affiliation":[{"name":"University of Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9691-2976","authenticated-orcid":false,"given":"Amynah","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Center for Clinical Pharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3883-4505","authenticated-orcid":false,"given":"Vsevolod","family":"Katritch","sequence":"additional","affiliation":[{"name":"USC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-9342","authenticated-orcid":false,"given":"Jay","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"University of Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2931-3823","authenticated-orcid":false,"given":"Susruta","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions","volume":"393","author":"Blanco C","year":"2019","unstructured":"Blanco C, Volkow ND (2019) Management of opioid use disorder in the USA: present status and future directions. Lancet 393:1760\u20131772","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jnr.24680","article-title":"Delta opioid receptor activation modulates affective pain and modality-specific pain hypersensitivity associated with chronic neuropathic pain","volume":"100","author":"Cahill CM","year":"2022","unstructured":"Cahill CM et al (2022) Delta opioid receptor activation modulates affective pain and modality-specific pain hypersensitivity associated with chronic neuropathic pain. J Neurosci Res 100:129\u2013148","journal-title":"J Neurosci Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnmol.2020.00052","article-title":"The Delta-Opioid Receptor; a Target for the Treatment of Pain","volume":"13","author":"Quirion B","year":"2020","unstructured":"Quirion B, Bergeron F, Blais V, Gendron L (2020) The Delta-Opioid Receptor; a Target for the Treatment of Pain. Front Mol Neurosci 13:52","journal-title":"Front Mol Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/bph.12591","article-title":"\u03b4-Opioid receptor agonists inhibit migraine\u2010related hyperalgesia, aversive state and cortical spreading depression in mice","volume":"171","author":"Pradhan AA","year":"2014","unstructured":"Pradhan AA, Smith ML, Zyuzin J, Charles A (2014) \u03b4-Opioid receptor agonists inhibit migraine\u2010related hyperalgesia, aversive state and cortical spreading depression in mice. Br J Pharmacol 171:2375\u20132384","journal-title":"Br J Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.103.061242","article-title":"\u03b4-Opioid Agonists: Differential Efficacy and Potency of SNC80, Its 3-OH (SNC86) and 3-Desoxy (SNC162) Derivatives in Sprague-Dawley Rats","volume":"309","author":"Jutkiewicz EM","year":"2004","unstructured":"Jutkiewicz EM et al (2004) \u03b4-Opioid Agonists: Differential Efficacy and Potency of SNC80, Its 3-OH (SNC86) and 3-Desoxy (SNC162) Derivatives in Sprague-Dawley Rats. J Pharmacol Exp Ther 309:173\u2013181","journal-title":"J Pharmacol Exp Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"16459","DOI":"10.1523\/JNEUROSCI.3748-10.2010","article-title":"Ligand-Directed Trafficking of the -Opioid Receptor In Vivo: Two Paths Toward Analgesic Tolerance","volume":"30","author":"Pradhan AAA","year":"2010","unstructured":"Pradhan AAA et al (2010) Ligand-Directed Trafficking of the -Opioid Receptor In Vivo: Two Paths Toward Analgesic Tolerance. J Neurosci 30:16459\u201316468","journal-title":"J Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nchembio.2334","article-title":"In silico design of novel probes for the atypical opioid receptor MRGPRX2","volume":"13","author":"Lansu K","year":"2017","unstructured":"Lansu K et al (2017) In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat Chem Biol 13:529\u2013536","journal-title":"Nat Chem Biol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/S0024-3205(00)00975-9","article-title":"Modulation of NMDA- and (\u03e9)TAN-67-induced nociception by GABAB receptors in the mouse spinal cord","author":"Yajima Y","year":"2000","unstructured":"Yajima Y et al (2000) Modulation of NMDA- and (\u03e9)TAN-67-induced nociception by GABAB receptors in the mouse spinal cord. Life Sci","journal-title":"Life Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1523\/JNEUROSCI.5345-11.2012","article-title":"\u03b4-Opioid Receptor Function in the Dorsal Striatum Plays a Role in High Levels of Ethanol Consumption in Rats","volume":"32","author":"Nielsen CK","year":"2012","unstructured":"Nielsen CK et al (2012) \u03b4-Opioid Receptor Function in the Dorsal Striatum Plays a Role in High Levels of Ethanol Consumption in Rats. J Neurosci 32:4540\u20134552","journal-title":"J Neurosci"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-8993(00)02096-5","article-title":"Effects of differential modulation of m-, d- and k-opioid systems on bicuculline-induced convulsions in the mouse","author":"Yajima Y","year":"2000","unstructured":"Yajima Y et al (2000) Effects of differential modulation of m-, d- and k-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res","journal-title":"Brain Res"},{"unstructured":"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00979953. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT00979953","key":"ref11"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1124\/jpet.119.258640","article-title":"A Novel G Protein\u2013Biased Agonist at the \u03b4 Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain","volume":"372","author":"Conibear AE","year":"2020","unstructured":"Conibear AE et al (2020) A Novel G Protein\u2013Biased Agonist at the \u03b4 Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain. J Pharmacol Exp Ther 372:224\u2013236","journal-title":"J Pharmacol Exp Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s40263-020-00738-0","article-title":"Single\u2013Blind, Placebo\u2013Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects","volume":"34","author":"Fossler MJ","year":"2020","unstructured":"Fossler MJ et al (2020) Single\u2013Blind, Placebo\u2013Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects. CNS Drugs 34:853\u2013865A Phase I, Randomized","journal-title":"CNS Drugs"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41586-022-05588-y","article-title":"Structure-based design of bitopic ligands for the \u00b5-opioid receptor","volume":"613","author":"Faouzi A","year":"2023","unstructured":"Faouzi A et al (2023) Structure-based design of bitopic ligands for the \u00b5-opioid receptor. Nature 613:767\u2013774","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-023-06030-7","article-title":"Ligand and G-protein selectivity in the \u03ba-opioid receptor","volume":"617","author":"Han J","year":"2023","unstructured":"Han J et al (2023) Ligand and G-protein selectivity in the \u03ba-opioid receptor. Nature 617:417\u2013425","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.cell.2023.10.029","article-title":"Molecular basis of opioid receptor signaling","volume":"186","author":"Che T","year":"2023","unstructured":"Che T, Roth BL (2023) Molecular basis of opioid receptor signaling. Cell 186:5203\u20135219","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"eaaz3140","DOI":"10.1126\/scisignal.aaz3140","article-title":"Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists","volume":"13","author":"Gillis A","year":"2020","unstructured":"Gillis A et al (2020) Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Sci Signal 13:eaaz3140","journal-title":"Sci Signal"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1021\/acs.jmedchem.1c01273","article-title":"A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects","volume":"64","author":"Chakraborty S","year":"2021","unstructured":"Chakraborty S et al (2021) A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects. J Med Chem 64:13873\u201313892","journal-title":"J Med Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1038\/s41467-021-23736-2","article-title":"Site selective C\u2013H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy","volume":"12","author":"Bhowmik S","year":"2021","unstructured":"Bhowmik S et al (2021) Site selective C\u2013H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy. Nat Commun 12:3858","journal-title":"Nat Commun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e56519","DOI":"10.7554\/eLife.56519","article-title":"Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site","volume":"10","author":"Uprety R","year":"2021","unstructured":"Uprety R et al (2021) Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site. eLife 10:e56519","journal-title":"eLife"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"769623","DOI":"10.3389\/fpsyt.2021.769623","article-title":"Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia","volume":"12","author":"Peris L","year":"2021","unstructured":"Peris L, Szerman N (2021) Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia. Front Psychiatry 12:769623","journal-title":"Front Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","article-title":"Dopamine Partial Agonists: A New Class of Antipsychotic","volume":"18","author":"Lieberman JA","year":"2004","unstructured":"Lieberman JA (2004) Dopamine Partial Agonists: A New Class of Antipsychotic. CNS Drugs 18:251\u2013267","journal-title":"CNS Drugs"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acschemneuro.2c00597","article-title":"Pharmacological Mechanism of the Non-hallucinogenic 5-HT 2A Agonist Ariadne and Analogs","volume":"14","author":"Cunningham MJ","year":"2023","unstructured":"Cunningham MJ et al (2023) Pharmacological Mechanism of the Non-hallucinogenic 5-HT 2A Agonist Ariadne and Analogs. ACS Chem Neurosci 14:119\u2013135","journal-title":"ACS Chem Neurosci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.str.2013.09.020","article-title":"The Role of a Sodium Ion Binding Site in the Allosteric Modulation of the A2A Adenosine G Protein-Coupled Receptor","volume":"21","author":"Guti\u00e9rrez-de-Ter\u00e1n H","year":"2013","unstructured":"Guti\u00e9rrez-de-Ter\u00e1n H et al (2013) The Role of a Sodium Ion Binding Site in the Allosteric Modulation of the A2A Adenosine G Protein-Coupled Receptor. Structure 21:2175\u20132185","journal-title":"Structure"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e92727","DOI":"10.1371\/journal.pone.0092727","article-title":"The 2.1 \u00c5 Resolution Structure of Cyanopindolol-Bound \u03b21-Adrenoceptor Identifies an Intramembrane Na\u2009+\u2009Ion that Stabilises the Ligand-Free Receptor","volume":"9","author":"Miller-Gallacher JL","year":"2014","unstructured":"Miller-Gallacher JL et al (2014) The 2.1 \u00c5 Resolution Structure of Cyanopindolol-Bound \u03b21-Adrenoceptor Identifies an Intramembrane Na\u2009+\u2009Ion that Stabilises the Ligand-Free Receptor. PLoS ONE 9:e92727","journal-title":"PLoS ONE"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"eaax2518","DOI":"10.1126\/sciadv.aax2518","article-title":"Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs","volume":"5","author":"Luginina A","year":"2019","unstructured":"Luginina A et al (2019) Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs. Sci Adv 5:eaax2518","journal-title":"Sci Adv"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.aan5468","article-title":"D 4 dopamine receptor high-resolution structures enable the discovery of selective agonists","volume":"358","author":"Wang S","year":"2017","unstructured":"Wang S et al (2017) D 4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Science 358:381\u2013386","journal-title":"Science"},{"author":"Zarzycka B","unstructured":"Zarzycka B, Zaidi SA, Roth BL, Katritch V Harnessing Ion-Binding Sites for GPCR Pharmacology. 25","first-page":"25","key":"ref28"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.182.4119.1359","article-title":"Opiate Agonists and Antagonists Discriminated by Receptor Binding in Brain","volume":"182","author":"Pert CB","year":"1973","unstructured":"Pert CB, Pasternak G, Snyder SH (1973) Opiate Agonists and Antagonists Discriminated by Receptor Binding in Brain. Science 182:1359\u20131361","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2014.03.002","article-title":"Allosteric sodium in class A GPCR signaling","volume":"39","author":"Katritch V","year":"2014","unstructured":"Katritch V et al (2014) Allosteric sodium in class A GPCR signaling. Trends Biochem Sci 39:233\u2013244","journal-title":"Trends Biochem Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.1219218","article-title":"Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions","volume":"337","author":"Liu W","year":"2012","unstructured":"Liu W et al (2012) Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions. Science 337:232\u2013236","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41467-018-07939-8","article-title":"Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists","volume":"10","author":"Sch\u00f6ppe J","year":"2019","unstructured":"Sch\u00f6ppe J et al (2019) Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists. Nat Commun 10:17","journal-title":"Nat Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/mol.114.095737","article-title":"Sodium Ion Binding Pocket Mutations and Adenosine A 2A Receptor Function","volume":"87","author":"Massink A","year":"2015","unstructured":"Massink A et al (2015) Sodium Ion Binding Pocket Mutations and Adenosine A 2A Receptor Function. Mol Pharmacol 87:305\u2013313","journal-title":"Mol Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"11102","DOI":"10.1038\/s41598-018-29475-7","article-title":"Allosteric sodium binding cavity in GPR3: a novel player in modulation of A\u03b2 production","volume":"8","author":"Capaldi S","year":"2018","unstructured":"Capaldi S et al (2018) Allosteric sodium binding cavity in GPR3: a novel player in modulation of A\u03b2 production. Sci Rep 8:11102","journal-title":"Sci Rep"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature12944","article-title":"Molecular control of \u03b4-opioid receptor signalling","volume":"506","author":"Fenalti G","year":"2014","unstructured":"Fenalti G et al (2014) Molecular control of \u03b4-opioid receptor signalling. Nature 506:191\u2013196","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nsmb.3014","article-title":"PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome","volume":"22","author":"Kroeze WK","year":"2015","unstructured":"Kroeze WK et al (2015) PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat Struct Mol Biol 22:362\u2013369","journal-title":"Nat Struct Mol Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.neuropharm.2017.06.019","article-title":"Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor","volume":"123","author":"Margolis EB","year":"2017","unstructured":"Margolis EB, Fujita W, Devi LA, Fields HL (2017) Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor. Neuropharmacology 123:420\u2013432","journal-title":"Neuropharmacology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","article-title":"TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome","volume":"16","author":"Olsen RHJ","year":"2020","unstructured":"Olsen RHJ et al (2020) TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat Chem Biol 16:841\u2013849","journal-title":"Nat Chem Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"eaax9115","DOI":"10.1126\/sciadv.aax9115","article-title":"Elucidating the active \u03b4-opioid receptor crystal structure with peptide and small-molecule agonists","volume":"5","author":"Claff T","year":"2019","unstructured":"Claff T et al (2019) Elucidating the active \u03b4-opioid receptor crystal structure with peptide and small-molecule agonists. Sci Adv 5:eaax9115","journal-title":"Sci Adv"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang Y","year":"2023","unstructured":"Wang Y et al (2023) Structures of the entire human opioid receptor family. Cell 186:413\u2013427e17","journal-title":"Cell"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41586-023-05789-z","article-title":"Autoregulation of GPCR signalling through the third intracellular loop","volume":"615","author":"Sadler F","year":"2023","unstructured":"Sadler F et al (2023) Autoregulation of GPCR signalling through the third intracellular loop. Nature 615:734\u2013741","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/prot.22927","article-title":"Salt bridges: Geometrically specific, designable interactions","volume":"79","author":"Donald JE","year":"2011","unstructured":"Donald JE, Kulp DW, DeGrado WF (2011) Salt bridges: Geometrically specific, designable interactions. Proteins 79:898\u2013915","journal-title":"Proteins"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00213-002-1179-y","article-title":"Convulsant activity of a non-peptidic \u03b4-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats","volume":"164","author":"Broom D","year":"2002","unstructured":"Broom D et al (2002) Convulsant activity of a non-peptidic \u03b4-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats. Psychopharmacology 164:42\u201348","journal-title":"Psychopharmacology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1111\/j.1460-9568.2008.06223.x","article-title":"Inflammatory pain is enhanced in delta opioid receptor-knockout mice","volume":"27","author":"Gav\u00e9riaux-Ruff C","year":"2008","unstructured":"Gav\u00e9riaux-Ruff C, Karchewski LA, Hever X, Matifas A, Kieffer BL (2008) Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur J Neurosci 27:2558\u20132567","journal-title":"Eur J Neurosci"},{"key":"ref45","first-page":"4257","volume":"25","author":"Faouzi A","year":"2020","unstructured":"Faouzi A, Varga BR, Majumdar S (2020) Biased Opioid Ligands Molecules 25:4257","journal-title":"Biased Opioid Ligands Molecules"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"106961","DOI":"10.1016\/j.phrs.2023.106961","article-title":"IUPHAR themed review: Opioid efficacy, bias, and selectivity","volume":"197","author":"Ramos-Gonzalez N","year":"2023","unstructured":"Ramos-Gonzalez N, Paul B, Majumdar S (2023) IUPHAR themed review: Opioid efficacy, bias, and selectivity. Pharmacol Res 197:106961","journal-title":"Pharmacol Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41589-022-01208-y","article-title":"Insights into distinct signaling profiles of the \u00b5OR activated by diverse agonists","volume":"19","author":"Qu Q","year":"2023","unstructured":"Qu Q et al (2023) Insights into distinct signaling profiles of the \u00b5OR activated by diverse agonists. Nat Chem Biol 19:423\u2013430","journal-title":"Nat Chem Biol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15760","author":"Varga BR","year":"2022","unstructured":"Varga BR, Streicher JM, Majumdar S (2022) Strategies towards safer opioid analgesics\u2014A review of old and upcoming targets. British J Pharmacology bph.15760 10.1111\/bph.15760"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41589-022-01247-5","article-title":"Structural basis of efficacy-driven ligand selectivity at GPCRs","volume":"19","author":"Powers AS","year":"2023","unstructured":"Powers AS et al (2023) Structural basis of efficacy-driven ligand selectivity at GPCRs. Nat Chem Biol 19:805\u2013814","journal-title":"Nat Chem Biol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4664764\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4664764\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T07:08:13Z","timestamp":1741936093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4664764\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":49,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4664764\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41467-025-57734-5","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,7,16]]},"subtype":"preprint"}}